Rybelsus, also known as semaglutide, operates as a once-daily medication aimed at managing blood sugar levels for those living with type 2 diabetes. The medication belongs to a class of treatments called GLP-1 receptor agonists. This type of drug mimics the incretin hormones the body naturally produces to stimulate insulin…